Mechanisms of biliary lipid secretion and their role in lipid homeostasis

Seminars in Liver Disease

Volumn 20, Issue 3, 2000, Pages 293-305

  Oude Elferink, R P J ^a   Groen, A K ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bile; Cholesterol; Phospholipid

Indexed keywords

BILE SALT; CARRIER PROTEIN; GLYCOPROTEIN P; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

BILE SECRETION; CHOLESTASIS; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HOMEOSTASIS; HUMAN; LIPID BILE LEVEL; LIPOPROTEIN BLOOD LEVEL; MEMBRANE COMPONENT; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; TRANSPORT KINETICS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE; BILE CANALICULI; CHOLESTASIS; HEPATOCYTES; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIPIDS; LIVER; MICE; P-GLYCOPROTEINS;

EID: 0033736679     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Role of the enterohepatic circulation of bile salts in lipoprotein metabolism
2. Regulation of rat biliary cholesterol secretion by agents that alter intrahepatic cholesterol metabolism
3. Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat
4. Dietary fish oil-induced changes in intrahepatic cholesterol transport and bile acid synthesis in rats
5. Dietary fish oil potentiates bile acid-induced cholesterol secretion into bile in rats
6. The transport of lipoprotein cholesterol into bile: A reassessment of kinetic studies in the experimental animal
7. Importance of high-density lipoprotein-phosphatidylcholine in secretion of phospholipid and cholesterol in bile
8. High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile
9. A receptor-mediated pathway for cholesterol homeostasis
10. Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism
11. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-1 of rat plasma high density lipoprotein: Selective delivery of cholesterol ester to liver, adrenal, and gonad
12. Uptake of high-density lipoprotein-associated apoprotein A-1 and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro
13. Identification of scavenger receptor sr-bi as a high density lipoprotein receptor
14. Selective uptake of high-density lipoprotein-associated cholesteryl esters by human hepatocytes in primary culture
15. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology
16. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population
17. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene
18. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
19. Biliary cholesterol excretion: A novel mechanism that regulates dietary cholesterol absorption
20. Newly synthesized cholesterol in human bile and plasma: Quantitation by mass isotopomer distribution analysis
21. CTP: Phosphocholine cytidylyltransferase
22. Phosphatidylethanolamine N-methyltransferase from liver
23. Cloning and expression of a novel phosphatidylethanolamine N-methyltransferase. A specific biochemical and cytological marker for a unique membrane fraction in rat liver
24. Regulation of phospholipid biosynthesis in isolated rat hepatocytes. Effect of different substrates
25. Disruption of the murine gene encoding phosphatidylethanolamine N-methyl-transferase
26. Biochemical and evolutionary significance of phospholipid methylation
27. Hepatic phosphatidylcholines: Evidence for synthesis in the rat by extensive reutilization of endogenous acylglycerides
28. Lipid flow in bile formation
29. Mathematical model of biliary lipid secretion: A quantitative analysis of physiological and biochemical data from man and other species
30. Hepatic canalicular membrane 1: The role of mdr2 P-glycoprotein in hepatobiliary lipid transport
31. Retrograde intrabiliary injection of amphipathic materials causes phospholipid secretion into bile
32. A biochemical dissection of the functional polarity of the plasma membrane of the hepatocyte
33. Liver cell membrane solubilization may control maximum secretory rate of cholic acid in the rat
34. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
35. The physiological role of mdr2 P-glycoprotein in hepatobiliary phospholipid transport
36. Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein
37. A non-micellar mode of cholesterol transport in human bile
38. Solubilisation of cholesterol in human bile
39. Partial characterization of a nonmicellar system of cholesterol solubilization in bile
40. Ultracentrifugal isolation of vesicular carriers of biliary chlesterol in native human and rat bile
41. Imaging biliary lipid secretion in the rat: Ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane
42. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy
43. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
44. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice
45. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-gp specifically translocates phosphatidylcholine
46. Atp-dependent phosphatidylcholine translocation in rat liver canalicular plasma membrane vesicles
47. Cell typedependent effect of phospholipid and cholesterol on bile salt cytotoxicity
48. Asymmetric distribution of phosphatidylcholine and sphingomyelin between micellar and vesicular phases: Potential implications for canalicular bile formation
49. The preferential interaction of cholesterol with different classes of phospholipids
50. Lateral domain formation in mixed monolayers containing cholesterol and dipalmitoylphosphatidylcholine or N-palmitoylsphingomyelin
51. Lateral domain formation in cholesterol/phospholipid monolayers as affected by the sterol side chain conformation
52. Role of membranes in bile formation. Comparison of the composition of bile and a liver-canalicular plasma membrane subfraction
53. Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver
54. Sphingomyelins of rat liver: Biliary enrichment with molecular species containing 16:0 fatty acids as compared to canalicular-enriched plasma membranes
55. In vitro evidence that phospholipid secretion into bile may be coordinated intracellularly by the combined actions of bile salts and the specific phosphatidylcholine transfer protein of liver
56. Cloning and characterization of a cDNA encoding the specific phosphatidylcholine transfer protein from bovine liver
57. Isolation of a protein from beef liver which specifically stimulates the exchange of phosphatidylcholine
58. Phospholipid transfer proteins revisited
59. Determinants of the selection of phosphatidylcholine molecular species of secretion into bile in the rat
60. Mice without phosphatidylcholine transfer protein have no defects in the secretion of phosphatidylcholine into bile or into lung airspaces
61. Purification ad properties of sterol carrier protein 2
62. Rat liver proteins capable of transferring phosphatidylethanollamine. Purification and transfer activity for other phospholipids and cholesterol
63. The sterol carrier protein-2 fatty acid binding site: An NMR, circular dichroic, and fluorescence spectroscopic determination
64. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function
65. Subcellular localization of sterol carrier protein-2 in rat hepatocytes: Its primary localization to peroxisomes
66. The non-specific lipid-transfer protein (sterol carrier protein 2) and its relationship to peroxisomes
67. Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice
68. Modulation of intrahepatic cholesterol trafficking - Evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transport into rat bile
69. Role of the hepatocyte microtubular system in the excretion of bile salts and biliary lipid: Implications for intracellular vesicular transport
70. Glycerophospholipids and cholesterol composition of bile in bile-fistula rats treated with monensin
71. Monensin action on the Golgi complex in perfused rat liver evidence against bile salt vesicular transport
72. The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells
73. Delineation of a novel hepatic route for the selective transfer of unesterified sterols from high-density lipoproteins to bile: Studies using the perfused rat liver
74. Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1
75. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters
76. Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes
77. Domain exchangeability between the multidrug transporter (MDR1) and phosphatidylcholine flippase (MDR2)
78. Studies of human MDR1-MDR2 chimeras demonstrate the functional exchangeability of a major transmembrane segment of the multidrug transporter and phosphatidylcholine flippase
79. Regulation of mdr2 p-glycoprotein expression by bile salts
80. Enhancement of mdr2 gene transcription mediates the biliary transfer of phosphatidylcholine supplied by an increased biosynthesis in the pravastatin-treated rat
81. 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins) induce haptic expression of the phospholipid translocase mdr2 in rats
82. Absorption and metabolism of dietary cholesterol
83. The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell
84. Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 p-glycoprotein-deficient mice
85. Postprandial chylomicron formation and fat absorption in multidrug resistance gene 2 P-glycoprotein-deficient mice
86. Clinical and biochemical findings in progressive familial intrahepatic cholestasis
87. Histologic pathology of the liver in progressive familial intrahepatic cholestasis
88. The effect of experimental cholestasis on the negative feedback regulation of cholesterol synthesis in rat liver
89. Effect of cholesterol feeding and biliary obstruction on hepatic cholesterol biosynthesis in the rat
90. Studies of hepatic cholesterol synthesis in experimental acute biliary obstruction
91. Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats
92. The hypercholesterolaemia of obstructive jaundice
93. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat
94. The relationship between serum lipids and skin xanthomata in eighteen patients with primary biliary cirrhosis